Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Short Interest Update

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totaling 2,069 shares, an increase of 93.4% from the November 30th total of 1,070 shares. Based on an average daily volume of 32,075 shares, the short-interest ratio is presently 0.1 days. Based on an average daily volume of 32,075 shares, the short-interest ratio is presently 0.1 days.

Hikma Pharmaceuticals Stock Performance

Shares of HKMPY stock traded up $0.32 on Monday, hitting $41.77. The company had a trading volume of 2,071 shares, compared to its average volume of 2,872. The company has a 50-day moving average price of $43.07 and a 200-day moving average price of $47.96. Hikma Pharmaceuticals has a twelve month low of $39.93 and a twelve month high of $59.26.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.

The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.